Drug Shortage Report for SODIUM BICARBONATE INJECTION, USP
| Report ID | 143253 |
| Drug Identification Number | 02486636 |
| Brand name | SODIUM BICARBONATE INJECTION, USP |
| Common or Proper name | Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq (mmol), 50 mL Vial |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM BICARBONATE |
| Strength(s) | 84MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-08-01 |
| Actual start date | |
| Estimated end date | 2021-08-16 |
| Actual end date | 2021-08-16 |
| Shortage status | Resolved |
| Updated date | 2021-08-17 |
| Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, our Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq (mmol), 50 mL Vial will be going on backorder, effective August 1, 2021 until August 20, 2021. Omega is an alternate supplier of Sodium Bicarbonate Injection, USP, 8.4% and has been informed of our impending supply interruption. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-08-17 | English | Compare |
| v5 | 2021-08-16 | French | Compare |
| v4 | 2021-08-16 | English | Compare |
| v3 | 2021-08-02 | English | Compare |
| v2 | 2021-07-29 | French | Compare |
| v1 | 2021-07-29 | English | Compare |
Showing 1 to 6 of 6